PDCD1 and cancer: Currently, cancer immunotherapy has progressed rapidly and has become an important scientific breakthrough of cancer treatment, especially the application of ICIs like anti-programmed cell death protein 1/anti-programmed cell death 1 ligand 1 (anti-PD-1/PD-L1) and anti-CTLA-4.